This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ge, H. Articles by Li, Y. Search for Related Content PubMed PubMed Citation Articles by Ge, H. Articles by Li, Y.

Activation of G Protein-Coupled Receptor 43 in Adipocytes Leads to Inhibition of Lipolysis and Suppression of Plasma Free Fatty Acids

Amgen Inc., South San Francisco, California 94080

Address all correspondence and requests for reprints to: Yang Li, Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080. E-mail: yangl{at}amgen.com.

G protein-coupled receptor 43 (GPR43) has been identified as a receptor for short-chain fatty acids that include acetate and propionate. A potential involvement of GPR43 in immune and inflammatory response has been previously suggested because its expression is highly enriched in immune cells. GPR43 is also expressed in a number of other tissues including adipocytes; however, the functional consequences of GPR43 activation in these other tissues are not clear. In this report, we focus on the potential functions of GPR43 in adipocytes. We show that adipocytes treated with GPR43 natural ligands, acetate and propionate, exhibit a reduction in lipolytic activity. This inhibition of lipolysis is the result of GPR43 activation, because this effect is abolished in adipocytes isolated from GPR43 knockout animals. In a mouse in vivo model, we show that the activation of GPR43 by acetate results in the reduction in plasma free fatty acid levels without inducing the flushing side effect that has been observed by the activation of nicotinic acid receptor, GPR109A. These results suggest a potential role for GPR43 in regulating plasma lipid profiles and perhaps aspects of metabolic syndrome.

This article has been cited by other articles:

				E. H. Jeninga, A. Bugge, R. Nielsen, S. Kersten, N. Hamers, C. Dani, M. Wabitsch, R. Berger, H. G. Stunnenberg, S. Mandrup, et al. Peroxisome Proliferator-activated Receptor {gamma} Regulates Expression of the Anti-lipolytic G-protein-coupled Receptor 81 (GPR81/Gpr81) J. Biol. Chem., September 25, 2009; 284(39): 26385 - 26393. [Abstract] [Full Text] [PDF]

				A. Wang, Z. Gu, B. Heid, R. M. Akers, and H. Jiang Identification and characterization of the bovine G protein-coupled receptor GPR41 and GPR43 genes J Dairy Sci, June 1, 2009; 92(6): 2696 - 2705. [Abstract] [Full Text] [PDF]

				E. P. Plaisance, M. Lukasova, S. Offermanns, Y. Zhang, G. Cao, and R. L. Judd Niacin stimulates adiponectin secretion through the GPR109A receptor Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E549 - E558. [Abstract] [Full Text] [PDF]

				C. Liu, J. Wu, J. Zhu, C. Kuei, J. Yu, J. Shelton, S. W. Sutton, X. Li, S. J. Yun, T. Mirzadegan, et al. Lactate Inhibits Lipolysis in Fat Cells through Activation of an Orphan G-protein-coupled Receptor, GPR81 J. Biol. Chem., January 30, 2009; 284(5): 2811 - 2822. [Abstract] [Full Text] [PDF]

				L. A. Stoddart, N. J. Smith, and G. Milligan International Union of Pharmacology. LXXI. Free Fatty Acid Receptors FFA1, -2, and -3: Pharmacology and Pathophysiological Functions Pharmacol. Rev., December 1, 2008; 60(4): 405 - 417. [Abstract] [Full Text] [PDF]

				T. Lee, R. Schwandner, G. Swaminath, J. Weiszmann, M. Cardozo, J. Greenberg, P. Jaeckel, H. Ge, Y. Wang, X. Jiao, et al. Identification and Functional Characterization of Allosteric Agonists for the G Protein-Coupled Receptor FFA2 Mol. Pharmacol., December 1, 2008; 74(6): 1599 - 1609. [Abstract] [Full Text] [PDF]